BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Retina
,
Holistic medicine
,
Lovastatin
,
rs2476601
,
BRAF
,
T cell differentiation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
1218-98-0
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for 1218-98-0
Explore Curated Studies Results
Literature
Most Relevant Literature
Deep Learning Approach to Automatize TMTV Calculations Regardless of Segmentation Methodology for Ma…
Glutathione and cystamine functionalized MoS2core-shell nanoparticles for enhanced electrochemical d…
Dietary habits in Greek children with functional constipation based on Rome III criteria: a school-b…
Modified Single-Walled Carbon Nanotube Membranes for the Elimination of Antibiotics from Water.
Visit-to-Visit Variability in Fasting Blood Glucose Predicts the New-Onset Heart Failure: Results Fr…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Treatment of Type 2 Diabetes With Linagliptin 2.5 mg Bid + Metformin 500 or 1000 mg Bid and Metformi…
Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM
The Peregrine Study: A Safety and Performance Study of Renal Denervation
Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes
Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ